Tissue factor-positive tumor microvesicles activate platelets and enhance thrombosis in mice

Venous thrombosis and cancer: from mouse models to clinical trials

(2015) Y. Hisada et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Tissue factor expressed by circulating cancer cell-derived microparticles drastically increases the incidence of deep vein thrombosis in mice

(2015) G. M. Thomas et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Statins, aspirin and risk of thromboembolic events in ovarian cancer patients

(2014) Ayelet Shai et al.   GYNECOLOGIC ONCOLOGY

Inhibition of platelet activation prevents the P-selectin and integrin-dependent accumulation of cancer cell microparticles and reduces tumor growth and metastasisin vivo

(2014) Soraya Mezouar et al.   INTERNATIONAL JOURNAL OF CANCER

Strengths and weaknesses of a new mouse model of thrombosis induced by inferior vena cava stenosis: communication from the SSC of the ISTH

(2014) J. Geddings et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Platelet Count Measured Prior to Cancer Development Is a Risk Factor for Future Symptomatic Venous Thromboembolism: The Tromsø Study

(2014) Hilde Jensvoll et al.   PLoS One

Platelets and Cancer-Associated Thrombosis

(2014) Gregory C. Connolly et al.   SEMINARS IN ONCOLOGY

Dose escalation of low molecular weight heparin in patients with recurrent cancer-associated thrombosis

(2014) Ryma Ihaddadene et al.   THROMBOSIS RESEARCH

Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients

(2013) J. E. Geddings et al.   BLOOD

Treatment of cancer-associated thrombosis

(2013) A. Y. Y. Lee et al.   BLOOD

Statins, aspirin and risk of venous thromboembolic events in breast cancer patients

(2013) Ayelet Shai et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Circulating microparticle tissue factor, thromboembolism and survival in pancreaticobiliary cancers

(2013) Anubha Bharthuar et al.   THROMBOSIS RESEARCH

Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer

(2012) J.-G. Wang et al.   BLOOD

Incidence of venous thromboembolism in patients with cancer – A cohort study using linked United Kingdom databases

(2012) Alex J. Walker et al.   EUROPEAN JOURNAL OF CANCER

Intratumoral tissue factor expression and risk of venous thromboembolism in brain tumor patients

(2012) Johannes Thaler et al.   THROMBOSIS RESEARCH

In Vivo Fluorescence Imaging of Large-Vessel Thrombosis in Mice

(2011) Brian C. Cooley   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

CalDAG-GEFI deficiency protects mice in a novel model of Fc RIIA-mediated thrombosis and thrombocytopenia

(2011) M. Stolla et al.   BLOOD

Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized Trial

(2011) Antonio Palumbo et al.   JOURNAL OF CLINICAL ONCOLOGY

Differential contributions of monocyte- and platelet-derived microparticles towards thrombin generation and fibrin formation and stability

(2011) M. M. ALEMAN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Hematopoietic and nonhematopoietic cell tissue factor activates the coagulation cascade in endotoxemic mice

(2010) R. Pawlinski et al.   BLOOD

Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997–2006

(2010) D P Cronin-Fenton et al.   BRITISH JOURNAL OF CANCER

Nitric oxide derivatives and soluble plasma selectins in patients with myeloproliferative neoplasms

(2010) Giuseppe Cella et al.   THROMBOSIS AND HAEMOSTASIS

Tissue Factor in Coagulation

(2009) Saulius Butenas et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Tumor-Derived Tissue Factor-Bearing Microparticles Are Associated With Venous Thromboembolic Events in Malignancy

(2009) J. I. Zwicker et al.   CLINICAL CANCER RESEARCH

Assessing Risk of Venous Thromboembolism in the Patient With Cancer

(2009) Alok A. Khorana et al.   JOURNAL OF CLINICAL ONCOLOGY

Cancer cell–derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo

(2009) Grace M. Thomas et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Dose escalation of low molecular weight heparin to manage recurrent venous thromboembolic events despite systemic anticoagulation in cancer patients

(2009) M. CARRIER et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Levels of microparticle tissue factor activity correlate with coagulation activation in endotoxemic mice

(2009) J.-G. WANG et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Microparticle-associated tissue factor activity in cancer patients with and without thrombosis

(2009) M. E. T. TESSELAAR et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)

(2009) R. SIMANEK et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism

(2009) David A. Manly et al.   THROMBOSIS RESEARCH

Detection of endogenous tissue factor levels in plasma using the calibrated automated thrombogram assay

(2009) Veronique Ollivier et al.   THROMBOSIS RESEARCH

Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation

(2008) M. DAVILA et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer

(2008) A. A. KHORANA et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells

(2008) Khalid Al-Nedawi et al.   NATURE CELL BIOLOGY